Inclusion Criteria:

          -  Participants must have histologically or cytologically confirmed prostate cancer,
             stage T1a, T2a or T2b prostate cancer using MRI staging.

          -  Life expectancy greater than 10 years.

          -  Participants must have ability to understand and the willingness to sign a written
             informed consent document or have a surrogate with the ability to understand and the
             willingness to sign a written informed consent for radical prostatectomy.

        Exclusion Criteria:

          -  Participants with any prior extensive pelvic surgery or pelvic fractures.

          -  Prior treatment for prostate cancer such as radiotherapy or focal therapy.

          -  Uncorrected coagulopathy.

          -  Active soft tissue or urinary infection.

          -  Poor surgical risk (defined as American Society of Anesthesiology score > 3)

          -  Any condition or history of illness or surgery that, in the opinion of the
             investigator, might confound the results of the study or pose additional risk to the
             patient (e.g. significant cardiovascular conditions that significantly affect the life
             expectancy, chronic opiate use, pain syndrome, or drug abuse.)

          -  Participants with uncontrolled intercurrent illness including, but not limited to
             ongoing or active infection, symptomatic congestive heart failure, unstable angina
             pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would
             limit compliance with study requirements